| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.075 | 0.08 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.055 | 0.08 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.08 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.09 | 0.08 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.05 | 0.08 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.08 |